Export

Xylometazoline
Essential medicine status
Section:
28. Ear, nose and throat medicines [c]
ATC codes: R01AA07
EMLc
Indication
Nasal congestion ICD11 code: MF11.7
INN
Xylometazoline
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Local > Nasal > Spray: 0.05% w/v equivalent to 0.5 mg per mL (EMLc)
EML status history
First added in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Sex
All
Age
Children (1 month - 12 years)
Age restriction
Not in children less than 3 months
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives to be reviewed (2023)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Xylometazoline
DrugBank
Xylometazoline
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended the therapeutic alternatives for xylometazoline nasal spray be reviewed.